Featured Research

from universities, journals, and other organizations

Genetic cause discovered for rare disorder of motor neurons

Date:
December 7, 2012
Source:
University of St George's London
Summary:
Scientists have identified an underlying genetic cause for a rare disorder of motor neurons, and believe this may help find causes of other related diseases.

Scientists have identified an underlying genetic cause for a rare disorder of motor neurons, and believe this may help find causes of other related diseases.

Disorders of motor neurons are a group of progressive neuromuscular disorders that damage the nervous system, causing muscle weakness and wasting. These diseases affect many thousands of people in the UK. A number are inherited but the causes of the majority remain unknown, and there are no cures.

The new study has discovered a gene mutation that causes a rare disorder of motor neurons called distal hereditary motor neuropathy (dHMN). The researchers say their findings raise a possibility that mutations of the same gene or genes with similar roles might underlie other disorders of motor neurons. This could open up the potential for new treatment options, not only for dHMN but also for the wider group of these disorders.

dHMN principally affects muscles of the hands and feet, and sometimes causes a hoarse voice. Symptoms usually begin during adolescence although this can vary from infancy to the mid-thirties.

The study to investigate possible genetic causes of dHMN was led by Professor Andrew Crosby and Dr Meriel McEntagart at St George's, University of London. It has been published in the American Journal of Human Genetics.

The researchers carried out genetic sequencing of 26 members of one family in which 14 members were affected by dHMN and 12 were not. The mutation was found in all the affected members of the family.

The mutation of the gene -- called SLC5A7 -- was found to disrupt the function of a molecule called the choline transporter (CHT). CHT is responsible for carrying an essential nutrient called choline to the neuromuscular junctions, the areas in the body where nerves meet muscles and that are essential for motor function. This disruption to the function of the neuromuscular junctions leads to the debilitating symptoms.

Mutations of other genes affecting the function of the neuromuscular junctions are known to cause other unrelated neuromuscular disorders. But this is the first time a mutation affecting these specific areas has been linked to any disorder of motor neurons.

Professor Andrew Crosby of St George's, University of London said: "This genetic mechanism has never been linked with a disorder of motor neurons, so it indicates a new biological basis for this group of conditions. Knowledge of the biological pathway related to dHMN will potentially allow us to develop possible treatment options."

Professor Crosby said the latest findings about dHMN will enable them to conduct genetic testing for risk of this rare disease in affected families, using an existing assay. This should also allow them to test for risk of other disorders related to the same genetic mechanism.

"This a very promising step that may provide clues about other unexplained disorders of motor neurons caused by a similar biological disease mechanism," added Professor Crosby.

"A goal now is to investigate this biological mechanism in other patients with unexplained degenerative disorders of motor neurons."


Story Source:

The above story is based on materials provided by University of St George's London. Note: Materials may be edited for content and length.


Journal Reference:

  1. KatyE.S. Barwick, Jane Wright, Saeed Al-Turki, MerielM. McEntagart, Ajith Nair, Barry Chioza, Ali Al-Memar, Hamid Modarres, MaryM. Reilly, KatherineJ. Dick, AliciaM. Ruggiero, RandyD. Blakely, MattE. Hurles, AndrewH. Crosby. Defective Presynaptic Choline Transport Underlies Hereditary Motor Neuropathy. The American Journal of Human Genetics, 2012; 91 (6): 1103 DOI: 10.1016/j.ajhg.2012.09.019

Cite This Page:

University of St George's London. "Genetic cause discovered for rare disorder of motor neurons." ScienceDaily. ScienceDaily, 7 December 2012. <www.sciencedaily.com/releases/2012/12/121207090437.htm>.
University of St George's London. (2012, December 7). Genetic cause discovered for rare disorder of motor neurons. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/12/121207090437.htm
University of St George's London. "Genetic cause discovered for rare disorder of motor neurons." ScienceDaily. www.sciencedaily.com/releases/2012/12/121207090437.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins